US SB1008 | 2017-2018 | 115th Congress

Status

Spectrum: Slight Partisan Bill (Republican 8-5)
Status: Introduced on May 2 2017 - 25% progression, died in committee
Action: 2017-05-02 - Read twice and referred to the Committee on the Judiciary.
Pending: Senate Judiciary Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Therapeutic Hemp Medical Access Act of 2017 This bill amends the Controlled Substances Act (CSA): to add definitions for the terms "cannabidiol," "cannabidiol-rich plants," and "tetrahydrocannabinol concentration"; to exclude cannabidiol and cannabidiol-rich plants from the definition of marijuana; and to remove cannabidiol and cannabidiol-rich plants from coverage under the CSA. It also specifies that no provision of this bill prohibits or restricts the use, production, or distribution of marijuana in a state in which such activities are legal under state law.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Therapeutic Hemp Medical Access Act of 2017

Sponsors


History

DateChamberAction
2017-05-02SenateRead twice and referred to the Committee on the Judiciary.

Same As/Similar To

HB2273 (Related) 2017-06-02 - Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

Subjects


US Congress State Sources


Bill Comments

feedback